ACLX
Companies
NASDAQ
Arcellx Inc.
Health Care
$63.79
-$12.90 (-16.82%)
Price Chart
Overview
About ACLX
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.
Market Cap
$2.7B
Volume
83.4M
Avg. Volume
52.1M
P/E Ratio
-26.004444
Dividend Yield
0.00%
Employees
104.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.47
Low Correlation
Volatility
High (0.52)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ACLX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$2.7B
Volume83.4M
P/E Ratio-26.00
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 28, 2025Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025